MENU

SXTP Stock Tickeron detected bullish Stock Pattern: Head-and-Shoulders Bottom on September 24, 2024

A.I.dvisor
at Tickeron.com
09/26/24
Loading...
Head-and-Shoulders Bottom
SXTP - 60 Degrees Pharmaceuticals Inc
Tickeron
Emerged: 09/24/24
Breakout: $1.44
Price: $1.33
Target price: $1.62
A.I.dvisor detected a bullish Head-and-Shoulders Bottom pattern for SXTP stock. This pattern was detected on September 24, 2024 . The odds of reaching the target price are 8. The Head-and-Shoulders Bottom pattern is formed when the price of a security creates a center trough (the inverted head, labeled 3) and the left and right inverted shoulders (1, 5). After reaching the lowest low (the Head, 3) the next low is shallower and the trend reverses course to the upside. Consider buying a security or a call option at the low once the pattern is confirmed, which is known as the breakout point. The pattern is confirmed when the price breaks above the Neckline (2,4).

SXTP's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for SXTP turned positive on November 04, 2024. Looking at past instances where SXTP's MACD turned positive, the stock continued to rise in of 7 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SXTP's RSI Indicator exited the oversold zone, of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 06, 2024. You may want to consider a long position or call options on SXTP as a result. In of 15 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SXTP advanced for three days, in of 52 cases, the price rose further within the following month. The odds of a continued upward trend are .

SXTP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 5 cases where SXTP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SXTP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SXTP entered a downward trend on October 30, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.171). P/E Ratio (0.000) is within average values for comparable stocks, (100.668). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.979). SXTP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (2.456) is also within normal values, averaging (227.804).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SXTP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SXTP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
SXTP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1025 Connecticut Avenue NW
Phone
+1 202 327-5422
Employees
3
Web
https://www.60degreespharma.com